Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.

Diğer sürümleri göster (1)

OBJECTIVE • To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS • Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices...

Detaylı Bibliyografya
Asıl Yazarlar:	Williams, N, Hughes, L, Turner, E, Donovan, J, Hamdy, F, Neal, D, Martin, R, Metcalfe, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
Yazar:: Williams, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Yazar:: Young, GJ, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Screening for prostate cancer remains controversial.
Yazar:: Neal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Yazar:: Brindle, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
Yazar:: Moore, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Yazar:: Macefield, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Yazar:: Simpkin, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
Yazar:: Burton, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Yazar:: Turner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
Yazar:: Neal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Yazar:: Tilling, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
Yazar:: Vickers, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Yazar:: Oliver, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Screening for prostate cancer. The case against.
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

10-year outcomes in localized prostate cancer.
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Prostate cancer: screening approaches.
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prostate cancer: screening approaches
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

10-year outcomes in localized prostate cancer: Authors' reply
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
Yazar:: Jalil Ibrahim Salih, ve diğerleri
Baskı/Yayın Bilgisi: (2013-08-01)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
Yazar:: Lamb, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
Yazar:: Mason, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)